Shankar Lal Rampal Dye-Chem Limited has announced the approval of its unaudited financial results for the quarter and nine months ended December 31, 2025. The Board of Directors convened on February 14, 2026, to consider and approve the financial statements in compliance with regulatory requirements.

Board Meeting Outcomes

The Board meeting, which commenced at 12:15 PM and concluded at 12:45 PM on February 14, 2026, addressed several key matters:

The directors approved the unaudited financial results for the quarter and nine months ended December 31, 2025, along with the limited review report from the statutory auditor for the same period. The company has committed to filing the results in XBRL format within stipulated timeframes and hosting them on its website at www.srdyechem.com .

Regulatory Compliance and Documentation

The company has fulfilled its regulatory obligations under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under section 133 of the Companies Act, 2013.

Key compliance aspects include:

• Audit Committee review and Board approval of unaudited financial results
• Limited review conducted by statutory auditors
• Submission to both BSE Limited and National Stock Exchange of India Limited
• Filing in XBRL format within stipulated timeframes

Auditor's Review and Business Operations

Laxman Kumar & Associates, Chartered Accountants, served as the statutory auditors and conducted the limited review of the financial statements. The auditors issued an unmodified opinion on the results, confirming compliance with applicable accounting standards and regulatory requirements. The review was conducted in accordance with Standard on Review Engagements (SRE) 2410.

The company has identified trading in dyes and chemicals business as its primary reportable segment in accordance with Ind AS 108 "Operating Segment" requirements. As of December 31, 2025, the company has no subsidiary, associate, or joint venture companies.

Stock Exchange Information

Company Secretary and Compliance Officer Aditi Babel (Membership No. F13506) coordinated the regulatory filings and ensured proper documentation. The company maintains its registered office at SG 2730, Suwana, Bhilwara, Rajasthan, and continues to focus on its core trading operations in dyes and chemicals.

Shankar Lal Rampal Dye-Chem Limited announced significant corporate developments following its board meeting held on January 12, 2026, at the company's registered office in Suwana, Bhilwara, Rajasthan. The meeting, which commenced at 5:00 PM and concluded at 5:20 PM, resulted in key approvals related to property acquisition and strategic authorizations.

Property Acquisition Approval

The board of directors approved the acquisition of immovable property with enhanced financial commitment compared to previous approvals. The decision reflects revised commercial terms and expanded investment scope for the company's property portfolio.

Supersession of Earlier Approval

The current approval supersedes the board's earlier decision dated November 13, 2025, which had sanctioned property acquisition for consideration below ₹1.00 crore. The revision demonstrates the company's adaptive approach to changing market conditions and commercial negotiations. The updated approval reflects revised commercial terms that necessitated increased financial allocation for the property acquisition.

Authorization and Implementation

The board granted comprehensive authorization to Executive Directors for transaction execution. This delegation includes authority to finalize and execute necessary agreements, deeds, and documents required for the property acquisition. The Executive Directors are empowered to perform all acts, deeds, and activities necessary or incidental to implement the board's resolution.

The acquisition remains subject to completion of customary documentation and compliance with applicable legal and regulatory requirements. This structured approach ensures proper due diligence and regulatory compliance throughout the acquisition process.

Corporate Governance Compliance

The announcement was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Aditi Babel signed the disclosure document, ensuring proper corporate governance protocols were followed. The company maintains transparency with stakeholders through timely disclosure of material developments and board decisions.